Can-Fite BioPharma Ltd.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | D. Boral Capital | upgrade | Hold → Buy | — | 34% |
| May 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Dec 24, 2025 | D. Boral Capital | downgrade | Buy → Hold | — | 34% |
| Dec 17, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Nov 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $11 | 34% |
| Sep 16, 2025 | D. Boral Capital | maintain | Buy → Buy | $11 | 34% |
| Sep 2, 2025 | D. Boral Capital | maintain | Buy → Buy | $11 | 34% |
| Jul 29, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Apr 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Mar 21, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Mar 20, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Mar 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Mar 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Feb 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Dec 31, 2024 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Dec 5, 2024 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Jul 17, 2024 | EF Hutton | initiate | — → Buy | $10 | 30% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Oct 24, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Jun 2, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $34 | 44% |
| Mar 13, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $34 | 44% |
No cross-platform signals in the last 90 days